Published in J Immunol on July 01, 1980
Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes. J Exp Med (1994) 2.18
New insights into the biology of the acute phase response. J Clin Immunol (1999) 2.05
Cell surface-bound elastase and cathepsin G on human neutrophils: a novel, non-oxidative mechanism by which neutrophils focus and preserve catalytic activity of serine proteinases. J Cell Biol (1995) 1.98
Elastase of U-937 monocytelike cells. Comparisons with elastases derived from human monocytes and neutrophils and murine macrophagelike cells. J Clin Invest (1982) 1.41
Isolation and characterization of the amyloid-related apoprotein (SAA) from human high density lipoprotein. Proc Natl Acad Sci U S A (1980) 1.32
Molecular mechanisms regulating NETosis in infection and disease. Semin Immunopathol (2013) 1.30
The degradation of serum amyloid A protein by activated polymorphonuclear leucocytes: participation of granulocytic elastase. Immunology (1982) 1.23
Serum amyloid A (SAA) in viral infection: rubella, measles and subacute sclerosing panencephalitis (SSPE). Clin Exp Immunol (1982) 1.16
Isolation and characterization of senile amyloid--related antigenic substance (SASSAM) from mouse serum. Apo SASSAM is a low molecular weight apoprotein of high density lipoprotein. J Exp Med (1983) 1.07
Characterization of human amyloid-related protein SAA as a polymorphic protein: association with albumin and prealbumin in serum. Clin Exp Immunol (1981) 0.99
Impaired Kupffer cell function precedes development of secondary amyloidosis. J Exp Med (1985) 0.98
Neutrophil association and degradation of normal and acute-phase high-density lipoprotein 3. Biochem J (1987) 0.95
Post-cardiac transplant arteriopathy in piglets is associated with fragmentation of elastin and increased activity of a serine elastase. Am J Pathol (1994) 0.93
Impaired degradation of serum amyloid A (SAA) protein by cytokine-stimulated monocytes. Clin Exp Immunol (2001) 0.89
Amyloidosis and the serum amyloid A protein response to muramyl dipeptide analogs and different mycobacterial species. Infect Immun (1983) 0.84
Serum amyloid A concentrations during the course of acute ischaemic heart disease. J Clin Pathol (1986) 0.83
Metabolism of senile amyloid precursor and amyloidogenesis. Age-related acceleration of apolipoprotein A-II clearance in the senescence accelerated mouse. Am J Pathol (1988) 0.81
Relation of the hepatic and splenic microcirculations to the development of lesions in experimental amyloidosis. Am J Pathol (1985) 0.77
Serum amyloid A protein (SAA) subtypes in acute and chronic inflammatory conditions. Ann Rheum Dis (1985) 0.77
Ultrastructural studies of vascular lesions in experimental amyloidosis of mice. Am J Pathol (1985) 0.75
The characterization of soluble amyloid prepared in water. J Clin Invest (1968) 6.17
Cryoglobulinemia--a clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity. Am J Med (1966) 5.26
Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MGDF in megakaryocyte development. Cell (1995) 4.32
The amino acid sequence of a major nonimmunoglobulin component of some amyloid fibrils. J Clin Invest (1972) 3.96
The interaction of mycoplasmas with mammalian cells. I. HeLa cells, neutrophils, and eosinophils. J Exp Med (1966) 3.38
Immunologic studies of the major nonimmunoglobulin protein of amyloid. I. Identification and partial characterization of a related serum component. J Exp Med (1973) 3.22
Studies on human platelet granules and membranes. J Clin Invest (1966) 3.22
Variation with age and disease of an amyloid A protein-related serum component. J Clin Invest (1975) 3.17
Cryoglobulinemia--a study of twenty-nine patients. I. IgG and IgM cryoglobulins and factors affecting cryoprecipitability. Am J Med (1966) 3.15
Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients. Am J Med (1980) 2.87
The percentage of monocytes among "mononuclear" cell fractions obtained from normal human blood. J Immunol (1974) 2.69
HTLV tax and mycosis fungoides. N Engl J Med (1993) 2.23
Degradation of serum amyloid A protein by surface-associated enzymes of human blood monocytes. J Exp Med (1978) 2.09
Isolation and partial characterization of SAA-an amyloid-related protein from human serum. J Immunol (1976) 2.05
The phagosomes in rheumatoid synovial fluid leukocytes: a light, fluorescence, and electron microscope study. Arthritis Rheum (1966) 1.93
The ultrastructure of lymphocytes. Semin Hematol (1969) 1.93
Preferential association of kappa IIIb light chains with monoclonal human IgM kappa autoantibodies. J Immunol (1983) 1.87
Association between hepatitis B virus and essential mixed cryoglobulinemia. N Engl J Med (1977) 1.86
Primary structure of the "hinge" region of human IgG3. Probable quadruplication of a 15-amino acid residue basic unit. J Biol Chem (1977) 1.83
Current concepts of amyloid. Adv Immunol (1972) 1.75
Depression of cellular-mediated immunity in systemic lupus erythematosus. relation to disease activity. Arthritis Rheum (1975) 1.73
Human monoclonal gamma G-cryoglobulins with anti-gamma-globulin activity. J Clin Invest (1968) 1.72
The actin and myosin filaments of human and bovine blood platelets. J Clin Invest (1972) 1.71
The submembranous fibrils of human blood platelets. J Cell Biol (1970) 1.70
Physical, chemical, and ultrastructural studies of water-soluble human amyloid fibrils. Comparative analyses of nine amyloid preparations. J Exp Med (1969) 1.66
Structural studies of human gamma-G-myeloma proteins of different antigenic subgroups and genetic specificities. J Exp Med (1966) 1.62
Therapeutic agents with dramatic antiretroviral activity and little toxicity at effective doses: aromatic polycyclic diones hypericin and pseudohypericin. Proc Natl Acad Sci U S A (1988) 1.60
Interaction of immunoglobulins with liposomes. J Clin Invest (1974) 1.58
The interaction of mycoplasmas with mammalian cells. II. Monocytes and lymphocytes. J Exp Med (1966) 1.57
Antiidiotypic activity in the IgM fractions of mixed cryoglobulins. J Immunol (1980) 1.55
Electron microscopic studies of human granulocytes: structural variations related to function. Semin Hematol (1968) 1.47
White cell reduction by filtration may significantly decrease human T-lymphotropic virus type 1 Tax sequences and Tax-encoded proteins in blood used for transfusion. Transfusion (1998) 1.44
Microfibrils of blood platelets: their relationship TO MICROTUBULES AND THE CONTRACTILE PROTEIN. J Clin Invest (1969) 1.43
Primary structure of an amyloid prealbumin variant in familial polyneuropathy of Jewish origin. Proc Natl Acad Sci U S A (1983) 1.42
Studies on antigen-binding activity of macroglobulin antibody subunits and their enzymatic fragments. J Biol Chem (1969) 1.41
A variant of prealbumin from amyloid fibrils in familial polyneuropathy of Jewish origin. J Exp Med (1981) 1.39
Thrombopoietin, the Mp1 ligand, is essential for full megakaryocyte development. Proc Natl Acad Sci U S A (1995) 1.39
Lymphocyte plasma membranes: analysis of proteins and glycoproteins by SDS-gel electrophoresis. Blood (1973) 1.38
Bence Jones proteins and light chains of immunoglobulins. Preferential association of the V lambda VI subgroup of human light chains with amyloidosis AL (lambda). J Clin Invest (1982) 1.37
Common structural and antigenic properties of human gamma M anti-gamma globulins. J Immunol (1971) 1.36
Electron microscopic study of isolated Kupffer cells. Am J Pathol (1969) 1.36
CD4-independent, productive human immunodeficiency virus type 1 infection of hepatoma cell lines in vitro. J Virol (1990) 1.34
Amyloidosis. Annu Rev Med (1981) 1.34
gamma Heavy chain disease in man: cDNA sequence supports partial gene deletion model. Proc Natl Acad Sci U S A (1982) 1.27
Amyloid-related serum component (SAA)--studies in acute infections, medullary thyroid carcinoma, and postsurgery. Clin Immunol Immunopathol (1976) 1.27
Leukemic cells with membrane properties of thymus-derived (T) lymphocytes in a case of Sézary's syndrome: morphologic and immunologic studies. Clin Immunol Immunopathol (1973) 1.27
Primary structure of human gamma 3 immunoglobulin deletion mutant: gamma 3 heavy-chain disease protein Wis. Biochemistry (1980) 1.26
Chemical typing of immunoglobulins. Nature (1969) 1.24
Ultrastructural, immunologic, and functional studies on Sézary cells: a neoplastic variant of thymus-derived (T) lymphocytes. Proc Natl Acad Sci U S A (1974) 1.24
Synthesis and assembly of immunoglobulins by malignant human plasmacytes. I. Myelomas producing gamma-chains and light chains. J Exp Med (1970) 1.23
Heavy chain diseases: clinical features and molecular significance of the disordered immunoglobulin structure. Semin Hematol (1973) 1.23
Eosinophil function and disorders. Adv Intern Med (1974) 1.22
Intrachain disulphide bridges in immunoglobulin G heavy chains. The Fc fragment. Biochem J (1968) 1.22
Transformation of monocytes into "fat" cells. Lab Invest (1978) 1.22
Polymorphism of tissue and serum amyloid A (AA and SAA) proteins in the mouse. J Immunol (1978) 1.22
Morphologic, chemical, and immunologic studies of amyloid-like fibrils formed from Bence Jones Proteins by proteolysis. J Immunol (1973) 1.21
Immunologic studies of proteins associated with subcellular fractions of normal human platelets. J Lab Clin Med (1967) 1.20
Ultrastructural evidence for the common origin of human mast cells and basophils. Blood (1980) 1.19
Intracellular localization of human amyloid by fluorescence and electron microscopy. Am J Pathol (1970) 1.16
Heterogeneity of 5'-nucleotidase activity in lymphocytes in chronic lymphocytic leukemia. J Clin Invest (1973) 1.14
Structural variants of human and murine immunoglobulins. Contemp Top Mol Immunol (1975) 1.14
Rheumatoid factors and the etiology of rheumatoid arthritis. Ann N Y Acad Sci (1965) 1.13
The molecular defect in a protein (CRA) found in gamma-1 heavy chain disease, and its genetic implications. Proc Natl Acad Sci U S A (1971) 1.13
Electron microscope study of surface immunoglobulin-bearing human tonsil cells. J Exp Med (1972) 1.12
Molecular defect in a gamma-2 heavy chain. Science (1972) 1.11
Amino acid sequence similarities between amyloid P component C1t and CRP. Nature (1977) 1.11
Thrombocytopoiesis--analysis by membrane tracer and freeze-fracture studies on fresh human and cultured mouse megakaryocytes. J Cell Biol (1984) 1.11
Pathologic effects of plasma from patients with thrombotic thrombocytopenic purpura on platelets and cultured vascular endothelial cells. Blood (1982) 1.09
Synthesis and assembly of immunoglobulins by malignant human plasmacytes and lymphocytes. II. Heterogeneity of assembly in cells producing IgM proteins. J Exp Med (1971) 1.09
Endocytosis by human platelets: metabolic and freeze-fracture studies. J Cell Biol (1981) 1.08
Proteolytic enzymes from the mouse submaxillary gland. Specificity restricted to arginine residues. Arch Biochem Biophys (1977) 1.08
Human lymphocytes: 5'-nucleotidase-positive and -negative subpopulations. J Clin Invest (1975) 1.07
The identification of eosinophil colonies in soft-agar cultures by differential staining for peroxidase. J Histochem Cytochem (1976) 1.07
Staphylococcal protein A and human IgG subclasses and allotypes. Scand J Immunol (1982) 1.06
Heavy-chain diseases. N Engl J Med (1970) 1.06
Immunophagocytosis of human amyloid fibrils by leukocytes. J Ultrastruct Res (1970) 1.06
Ultrastructure of thrombosthenin, the contractile protein of human blood platelets. Science (1967) 1.05
AA protein in a case of "primary" or "idiopathic" amyloidosis. Am J Med (1980) 1.05
Similarities of the light chains and the variable regions of the heavy chains of the IgG2 lambda and IgA1 lambda myeloma proteins from a single patient. J Immunol (1974) 1.04
Arylsulfatase in natural killer cells: its possible role in cytotoxicity. Proc Natl Acad Sci U S A (1983) 1.04
The detection of a common idiotype of anti-DNA antibodies in the sera of patients with monoclonal gammopathies. J Clin Immunol (1986) 1.04
The formation of amyloid-like fibrils in vitro from Bence Jones Proteins of the VlambdaI subclass. J Immunol (1973) 1.04
Human monoclonal macroglobulins with specificity for Klebsiella K polysaccharides that contain 3,4-pyruvylated-D-galactose and 4,6-pyruvylated-D-galactose. J Exp Med (1980) 1.04
The cutaneous T cell lymphoma, mycosis fungoides, is a human T cell lymphotropic virus-associated disease. A study of 50 patients. J Clin Invest (1995) 1.04
Increased lecithin synthesis during phagocytosis by normal leukocytes and by leukocytes of a patient with chronic granulomatous disease. N Engl J Med (1969) 1.04
Differences in the behavior of the membrane and membrane-associated filamentous structures in normal and chronic lymphocytic leukemia (CLL) lymphocytes. J Immunol (1979) 1.04
Monoclonal anti-tuberculosis antibodies react with DNA, and monoclonal anti-DNA autoantibodies react with Mycobacterium tuberculosis. Clin Exp Immunol (1986) 1.03
Immunoglobulin M heavy chain disease: intracellular origin of the mu chain fragment. Science (1970) 1.02
Subtilisin and cyanogen bromide cleavage products of fibronectin that retain gelatin-binding activity. Proc Natl Acad Sci U S A (1979) 1.02
Notation for human immunogobulin subclasses. Bull World Health Organ (1966) 1.01
A "new" phenotype confirming a relationship between Cra and Tca. Transfusion (1984) 1.01